HLTH 2024 Begins Today
HLTH USA 2024 is finally here! The conversations around data, AI, and healthcare innovation are more important than ever. Imagine a world where real-time patient data can help us not just treat but anticipate the needs of rare disease patients. That’s what we’re here to discuss at Clinakos Inc. —how to turn data into actionable […]
Breast Cancer Awareness Month
Breast cancer is most treatable when caught early. Regular self-exams, screenings, and mammograms can make all the difference. Don’t ignore the signs—take action now. Early detection isn’t just a medical procedure; it’s the difference between worry and peace of mind, between fear and strength. This Breast Cancer Awareness Month, let’s empower ourselves and the women […]
The Power of a Diagnosis
For years, Anthony’s family lived in a state of uncertainty. His symptoms were complex and baffling, leaving doctors without answers and his parents without a path forward. The fear of not knowing what their son was up against grew heavier with each passing day. Then, everything changed. Through a groundbreaking AI algorithm developed at CHEO, […]
Meet us at HLTH USA 2024
We’re thrilled to announce that Clinakos Inc. will be at HLTH USA 2024 in Las Vegas, October 20-23, joining over 12,000 attendees at one of the biggest healthcare events of the year! Join us to discover how Integrated Patient Data™ and Medically Smart AI™ are powering innovative solutions for life sciences. From access to niche […]
Intellus Worldwide 2024
A shoutout to the Intellus Worldwide Institute for an exciting lineup of topics at this year’s conference, covering critical areas such as the use of technology and data for deeper insights and patient engagement! These are more than just trends—they are shaping the future of life sciences and patient outcomes. At Clinakos Inc., we’re fully […]
Advantages of Clinakos’ Approach For Commercial
The McKinsey Global Institute (MGI) estimates that AI technologies could generate between $60 billion and $110 billion annually for the pharmaceutical and medical-product industries. At Clinakos Inc., we harness the power of Integrated Patient Data™ and Medically Smart AI™ to deliver real-time insights that drive smarter, faster decisions in life sciences. Our platform builds 360-degree […]
Breaking Barriers in Rare Disease Research with Clinakos
According to the National Organization for Rare Disorders (NORD), over 7,000 rare diseases impact millions of patients, yet fewer than 500 have FDA-approved treatments. For patients living with rare diseases, the journey to a diagnosis is often long and difficult, with many facing misdiagnoses or remaining undiagnosed for years. At Clinakos Inc., we’re dedicated to […]
Driving Better Patient Outcomes in Cancer Research
In 2023, nearly 1.9 million new cancer cases were diagnosed in the U.S., with over 600,000 lives lost, according to the American Cancer Society. These numbers serve as a stark reminder of the urgent need for breakthroughs in oncology research and cancer treatment. At Clinakos Inc., we are at the forefront of this fight. Our […]
Exploring the New Frontiers in Real-World Evidence
The FDA‘s recent guidance on using real-world evidence (RWE) in observational research has opened new pathways for innovation in healthcare research. As we embrace these changes, it’s crucial to consider how we can further enhance the utility of #RWE. Here are three pivotal areas where expanded FDA guidance could significantly impact the future of healthcare […]
Transforming Lifesciences with NLP
According to Gramener, a Gartner-recognized company, Natural Language Processing (NLP) is projected to add $4.3 billion in revenue to the healthcare market by 2026. Clinakos Inc.‘s Medically Smart AI™ leverages NLP and Machine Learning (ML) to ignite innovation and improve patient outcomes. Our AI-driven insights are backed by advanced data science techniques, refined on vast […]
